Vopec Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 1.23 Cr
as on 09-12-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
as on 09-12-2024
- Revenue 19.91%
(FY 2022)
- Profit 94.78%
(FY 2022)
- Ebitda -319.95%
(FY 2022)
- Net Worth -3.58%
(FY 2022)
- Total Assets 6.74%
(FY 2022)
About Vopec Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.23 Cr.
The company currently has active open charges totaling ₹0.50 M.
Yadeesh Balasubramanyam, Sonja Benkovich, and Murugan Dinesh serve as directors at the Company.
- CIN/LLPIN
U24231TN1996PTC035357
- Company No.
035357
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vopec Pharmaceuticals Private Limited offer?
Vopec Pharmaceuticals Private Limited offers a wide range of products and services, including Sexual Wellness Products, Erectile Dysfunction Medicine, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Common Disease Medicines, Cough Syrup, Ayurvedic & Herbal Health Supplement, Herbal Supplements, Ayurvedic Churna and Goli, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Vopec Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yadeesh Balasubramanyam  | Additional Director | 20-Jan-2024 | Current |
Sonja Benkovich  | Additional Director | 21-Jul-2021 | Current |
| Murugan Dinesh | Additional Director | 21-Jul-2021 | Current |
Financial Performance of Vopec Pharmaceuticals.
Vopec Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.91% increase. The company also saw a substantial improvement in profitability, with a 94.78% increase in profit. The company's net worth dipped by a decrease of 3.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vopec Pharmaceuticals?
In 2022, Vopec Pharmaceuticals had a promoter holding of 100.00% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
East West Integrative Research Institute Private LimitedActive 11 years 5 monthsSonja Benkovich is a mutual person
American International Academy India Private LimitedActive 11 years 5 monthsSonja Benkovich is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 12 Mar 2010 | ₹0.50 M | Open |
How Many Employees Work at Vopec Pharmaceuticals?
Vopec Pharmaceuticals has a workforce of 16 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vopec Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vopec Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
